TISIDB

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway

> Subcellular Location, Domain and Function [ TOP ]
Subcellular Location	Nucleus membrane Peripheral membrane protein Nucleus, nuclear pore complex Nucleus envelope Note=Localizes at the nuclear basket and at or near the nuclear entry to the gated channel of the pore.
Domain	PF04097 Nup93/Nic96
Function	Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance (PubMed:9348540). May anchor nucleoporins, but not NUP153 and TPR, to the NPC. During renal development, regulates podocyte migration and proliferation through SMAD4 signaling (PubMed:26878725).

> Gene Ontology [ TOP ]
Biological Process	GO:0000302 response to reactive oxygen species GO:0001655 urogenital system development GO:0001667 ameboidal-type cell migration GO:0001822 kidney development GO:0002064 epithelial cell development GO:0006403 RNA localization GO:0006405 RNA export from nucleus GO:0006406 mRNA export from nucleus GO:0006409 tRNA export from nucleus GO:0006606 protein import into nucleus GO:0006913 nucleocytoplasmic transport GO:0006979 response to oxidative stress GO:0006997 nucleus organization GO:0006998 nuclear envelope organization GO:0006999 nuclear pore organization GO:0007077 mitotic nuclear envelope disassembly GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007184 SMAD protein import into nucleus GO:0008643 carbohydrate transport GO:0008645 hexose transport GO:0009266 response to temperature stimulus GO:0009408 response to heat GO:0010035 response to inorganic substance GO:0010631 epithelial cell migration GO:0010827 regulation of glucose transport GO:0015749 monosaccharide transport GO:0015758 glucose transport GO:0015931 nucleobase-containing compound transport GO:0016458 gene silencing GO:0016925 protein sumoylation GO:0016973 poly(A)+ mRNA export from nucleus GO:0017038 protein import GO:0018205 peptidyl-lysine modification GO:0019058 viral life cycle GO:0019080 viral gene expression GO:0019083 viral transcription GO:0030397 membrane disassembly GO:0031047 gene silencing by RNA GO:0032386 regulation of intracellular transport GO:0032388 positive regulation of intracellular transport GO:0032835 glomerulus development GO:0033157 regulation of intracellular protein transport GO:0034504 protein localization to nucleus GO:0034599 cellular response to oxidative stress GO:0034605 cellular response to heat GO:0034614 cellular response to reactive oxygen species GO:0035850 epithelial cell differentiation involved in kidney development GO:0036473 cell death in response to oxidative stress GO:0036474 cell death in response to hydrogen peroxide GO:0042306 regulation of protein import into nucleus GO:0042307 positive regulation of protein import into nucleus GO:0042542 response to hydrogen peroxide GO:0044033 multi-organism metabolic process GO:0044744 protein targeting to nucleus GO:0044766 multi-organism transport GO:0046794 transport of virus GO:0046822 regulation of nucleocytoplasmic transport GO:0046824 positive regulation of nucleocytoplasmic transport GO:0046931 pore complex assembly GO:0050657 nucleic acid transport GO:0050658 RNA transport GO:0051028 mRNA transport GO:0051031 tRNA transport GO:0051081 nuclear envelope disassembly GO:0051168 nuclear export GO:0051169 nuclear transport GO:0051170 nuclear import GO:0051222 positive regulation of protein transport GO:0051236 establishment of RNA localization GO:0051292 nuclear pore complex assembly GO:0060390 regulation of SMAD protein import into nucleus GO:0060391 positive regulation of SMAD protein import into nucleus GO:0060395 SMAD protein signal transduction GO:0061005 cell differentiation involved in kidney development GO:0061318 renal filtration cell differentiation GO:0070301 cellular response to hydrogen peroxide GO:0071166 ribonucleoprotein complex localization GO:0071426 ribonucleoprotein complex export from nucleus GO:0071427 mRNA-containing ribonucleoprotein complex export from nucleus GO:0071431 tRNA-containing ribonucleoprotein complex export from nucleus GO:0072001 renal system development GO:0072006 nephron development GO:0072009 nephron epithelium development GO:0072010 glomerular epithelium development GO:0072015 glomerular visceral epithelial cell development GO:0072073 kidney epithelium development GO:0072112 glomerular visceral epithelial cell differentiation GO:0072310 glomerular epithelial cell development GO:0072311 glomerular epithelial cell differentiation GO:0075733 intracellular transport of virus GO:0090092 regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090100 positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090130 tissue migration GO:0090132 epithelium migration GO:0090316 positive regulation of intracellular protein transport GO:0090521 glomerular visceral epithelial cell migration GO:1900034 regulation of cellular response to heat GO:1900180 regulation of protein localization to nucleus GO:1900182 positive regulation of protein localization to nucleus GO:1900407 regulation of cellular response to oxidative stress GO:1900408 negative regulation of cellular response to oxidative stress GO:1901031 regulation of response to reactive oxygen species GO:1901032 negative regulation of response to reactive oxygen species GO:1902579 multi-organism localization GO:1902581 multi-organism cellular localization GO:1902583 multi-organism intracellular transport GO:1902593 single-organism nuclear import GO:1902882 regulation of response to oxidative stress GO:1902883 negative regulation of response to oxidative stress GO:1903201 regulation of oxidative stress-induced cell death GO:1903202 negative regulation of oxidative stress-induced cell death GO:1903205 regulation of hydrogen peroxide-induced cell death GO:1903206 negative regulation of hydrogen peroxide-induced cell death GO:1903533 regulation of protein targeting GO:1903829 positive regulation of cellular protein localization GO:1904589 regulation of protein import GO:1904591 positive regulation of protein import GO:1904951 positive regulation of establishment of protein localization
Molecular Function	GO:0017056 structural constituent of nuclear pore
Cellular Component	GO:0005635 nuclear envelope GO:0005643 nuclear pore GO:0031965 nuclear membrane GO:0034399 nuclear periphery

> KEGG and Reactome Pathway [ TOP ]
KEGG	hsa03013 RNA transport
Reactome	R-HSA-168276: NS1 Mediated Effects on Host Pathways R-HSA-1169410: Antiviral mechanism by IFN-stimulated genes R-HSA-1640170: Cell Cycle R-HSA-69278: Cell Cycle, Mitotic R-HSA-3371556: Cellular response to heat stress R-HSA-2262752: Cellular responses to stress R-HSA-1280215: Cytokine Signaling in Immune system R-HSA-1643685: Disease R-HSA-168274: Export of Viral Ribonucleoproteins from Nucleus R-HSA-74160: Gene Expression R-HSA-211000: Gene Silencing by RNA R-HSA-70153: Glucose transport R-HSA-162906: HIV Infection R-HSA-162587: HIV Life Cycle R-HSA-189200: Hexose transport R-HSA-162909: Host Interactions of HIV factors R-HSA-168253: Host Interactions with Influenza Factors R-HSA-1169408: ISG15 antiviral mechanism R-HSA-168256: Immune System R-HSA-5663205: Infectious disease R-HSA-168254: Influenza Infection R-HSA-168255: Influenza Life Cycle R-HSA-168273: Influenza Viral RNA Transcription and Replication R-HSA-177243: Interactions of Rev with host cellular proteins R-HSA-176033: Interactions of Vpr with host cellular proteins R-HSA-913531: Interferon Signaling R-HSA-162599: Late Phase of HIV Life Cycle R-HSA-68886: M Phase R-HSA-1430728: Metabolism R-HSA-71387: Metabolism of carbohydrates R-HSA-194441: Metabolism of non-coding RNA R-HSA-392499: Metabolism of proteins R-HSA-68875: Mitotic Prophase R-HSA-168333: NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-2980766: Nuclear Envelope Breakdown R-HSA-3301854: Nuclear Pore Complex (NPC) Disassembly R-HSA-180746: Nuclear import of Rev protein R-HSA-597592: Post-translational protein modification R-HSA-72203: Processing of Capped Intron-Containing Pre-mRNA R-HSA-170822: Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-3371453: Regulation of HSF1-mediated heat shock response R-HSA-165054: Rev-mediated nuclear export of HIV RNA R-HSA-425407: SLC-mediated transmembrane transport R-HSA-3108232: SUMO E3 ligases SUMOylate target proteins R-HSA-2990846: SUMOylation R-HSA-3108214: SUMOylation of DNA damage response and repair proteins R-HSA-4615885: SUMOylation of DNA replication proteins R-HSA-4570464: SUMOylation of RNA binding proteins R-HSA-5578749: Transcriptional regulation by small RNAs R-HSA-382551: Transmembrane transport of small molecules R-HSA-72202: Transport of Mature Transcript to Cytoplasm R-HSA-159231: Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159236: Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159234: Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-168271: Transport of Ribonucleoproteins into the Host Nucleus R-HSA-159230: Transport of the SLBP Dependant Mature mRNA R-HSA-159227: Transport of the SLBP independent Mature mRNA R-HSA-168325: Viral Messenger RNA Synthesis R-HSA-180910: Vpr-mediated nuclear import of PICs R-HSA-191859: snRNP Assembly R-HSA-72306: tRNA processing R-HSA-6784531: tRNA processing in the nucleus

> KEGG and Reactome Pathway

[ TOP ]

KEGG

hsa03013 RNA transport

Reactome

R-HSA-168276: NS1 Mediated Effects on Host Pathways
R-HSA-1169410: Antiviral mechanism by IFN-stimulated genes
R-HSA-1640170: Cell Cycle
R-HSA-69278: Cell Cycle, Mitotic
R-HSA-3371556: Cellular response to heat stress
R-HSA-2262752: Cellular responses to stress
R-HSA-1280215: Cytokine Signaling in Immune system
R-HSA-1643685: Disease
R-HSA-168274: Export of Viral Ribonucleoproteins from Nucleus
R-HSA-74160: Gene Expression
R-HSA-211000: Gene Silencing by RNA
R-HSA-70153: Glucose transport
R-HSA-162906: HIV Infection
R-HSA-162587: HIV Life Cycle
R-HSA-189200: Hexose transport
R-HSA-162909: Host Interactions of HIV factors
R-HSA-168253: Host Interactions with Influenza Factors
R-HSA-1169408: ISG15 antiviral mechanism
R-HSA-168256: Immune System
R-HSA-5663205: Infectious disease
R-HSA-168254: Influenza Infection
R-HSA-168255: Influenza Life Cycle
R-HSA-168273: Influenza Viral RNA Transcription and Replication
R-HSA-177243: Interactions of Rev with host cellular proteins
R-HSA-176033: Interactions of Vpr with host cellular proteins
R-HSA-913531: Interferon Signaling
R-HSA-162599: Late Phase of HIV Life Cycle
R-HSA-68886: M Phase
R-HSA-1430728: Metabolism
R-HSA-71387: Metabolism of carbohydrates
R-HSA-194441: Metabolism of non-coding RNA
R-HSA-392499: Metabolism of proteins
R-HSA-68875: Mitotic Prophase
R-HSA-168333: NEP/NS2 Interacts with the Cellular Export Machinery
R-HSA-2980766: Nuclear Envelope Breakdown
R-HSA-3301854: Nuclear Pore Complex (NPC) Disassembly
R-HSA-180746: Nuclear import of Rev protein
R-HSA-597592: Post-translational protein modification
R-HSA-72203: Processing of Capped Intron-Containing Pre-mRNA
R-HSA-170822: Regulation of Glucokinase by Glucokinase Regulatory Protein
R-HSA-3371453: Regulation of HSF1-mediated heat shock response
R-HSA-165054: Rev-mediated nuclear export of HIV RNA
R-HSA-425407: SLC-mediated transmembrane transport
R-HSA-3108232: SUMO E3 ligases SUMOylate target proteins
R-HSA-2990846: SUMOylation
R-HSA-3108214: SUMOylation of DNA damage response and repair proteins
R-HSA-4615885: SUMOylation of DNA replication proteins
R-HSA-4570464: SUMOylation of RNA binding proteins
R-HSA-5578749: Transcriptional regulation by small RNAs
R-HSA-382551: Transmembrane transport of small molecules
R-HSA-72202: Transport of Mature Transcript to Cytoplasm
R-HSA-159231: Transport of Mature mRNA Derived from an Intronless Transcript
R-HSA-159236: Transport of Mature mRNA derived from an Intron-Containing Transcript
R-HSA-159234: Transport of Mature mRNAs Derived from Intronless Transcripts
R-HSA-168271: Transport of Ribonucleoproteins into the Host Nucleus
R-HSA-159230: Transport of the SLBP Dependant Mature mRNA
R-HSA-159227: Transport of the SLBP independent Mature mRNA
R-HSA-168325: Viral Messenger RNA Synthesis
R-HSA-180910: Vpr-mediated nuclear import of PICs
R-HSA-191859: snRNP Assembly
R-HSA-72306: tRNA processing
R-HSA-6784531: tRNA processing in the nucleus

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Literatures that report relations between NUP93 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.

> Text Mining [ TOP ]
There is no record.

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.

> High-throughput Screening

[ TOP ]

Statistical results of NUP93 in screening data sets for detecting immune reponses.

PMID	Screening System	Cancer Type	Cell Line	Data Set	Statistical Results	Relation to immunity
29301958	CRISPR-Cas9	melanoma	B16F10	Pmel-1 T cell	NA/NS	NA/NS
29301958	CRISPR-Cas9	melanoma	B16F10	OT-1 T cell	NA/NS	NA/NS
28783722	CRISPR-Cas9	melanoma	Mel624	2CT-CRISPR	Second most enriched score: 0.65	Sensitive to T cell-mediated killing
28723893	CRISPR-Cas9	melanoma	B16	GVAX+Anti-PD1	NA/NS	NA/NS
28723893	CRISPR-Cas9	melanoma	B16	GVAX	NA/NS	NA/NS
25691366	RNAi	Breast cancer	MCF7	Luc-CTL assay	NA/NS	NA/NS
24476824	shRNA	melanoma	B16	Primary screen	NA/NS	NA/NS
24476824	shRNA	melanoma	B16	Secondary screen	NA/NS	NA/NS

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders

> Expression difference between responders and non-responders

[ TOP ]

Points in the above scatter plot represent the expression difference of NUP93 in various data sets.

No	PMID	Cancer type	Group	Drug	# Res	# NRes	Log2 (Fold Change)	P value
1	26997480	Melanoma	all	Anti-PD-1 (pembrolizumab and nivolumab)	14	12	0.125	0.642
2	26997480	Melanoma	MAPKi	Anti-PD-1 (pembrolizumab and nivolumab)	6	5	0.737	0.732
3	26997480	Melanoma	non-MAPKi	Anti-PD-1 (pembrolizumab and nivolumab)	8	7	-0.328	0.844
4	28552987	Urothelial cancer	all	Anti-PD-L1 (atezolizumab)	9	16	-0.223	0.285
5	28552987	Urothelial cancer	smoking	Anti-PD-L1 (atezolizumab)	5	9	-0.496	0.795
6	28552987	Urothelial cancer	non-smoking	Anti-PD-L1 (atezolizumab)	4	7	0.124	0.96
7	29033130	Melanoma	all	Anti-PD-1 (nivolumab)	26	23	0.075	0.838
8	29033130	Melanoma	NIV3-PROG	Anti-PD-1 (nivolumab)	15	11	-0.167	0.92
9	29033130	Melanoma	NIV3-NAIVE	Anti-PD-1 (nivolumab)	11	12	0.425	0.808
10	29301960	Clear cell renal cell carcinoma (ccRCC)	all	Anti-PD-1 (nivolumab)	4	8	0.51	0.732
11	29301960	Clear cell renal cell carcinoma (ccRCC)	VEGFRi	Anti-PD-1 (nivolumab)	2	0	0	1
12	29301960	Clear cell renal cell carcinoma (ccRCC)	non-VEGFRi	Anti-PD-1 (nivolumab)	2	8	0.71	0.757
13	29443960	Urothelial cancer	all	Anti-PD-L1 (atezolizumab)	68	230	0.025	0.676

> Mutation difference between responders and non-responders

[ TOP ]

Points in the above scatter plot represent the mutation difference of NUP93 in various data sets.

No	PMID	Cancer type	Group	Drug	# Res	# NRes	% Mut/Res	% Mut/NRes	% Diff (R vs NR)	Pval
1	25765070	Non-small cell lung cancer (NSCLC)	all	Anti-PD-1 (pembrolizumab)	14	17	0	0	0	1
2	25765070	Non-small cell lung cancer (NSCLC)	smoking	Anti-PD-1 (pembrolizumab)	10	3	0	0	0	1
3	25765070	Non-small cell lung cancer (NSCLC)	non-smoking	Anti-PD-1 (pembrolizumab)	4	14	0	0	0	1
4	26359337	Melanoma	all	Anti-CTLA-4 (ipilimumab)	27	73	0	0	0	1
5	26359337	Melanoma	BRAFi	Anti-CTLA-4 (ipilimumab)	0	14	0	0	0	1
6	26359337	Melanoma	non-BRAFi	Anti-CTLA-4 (ipilimumab)	27	59	0	0	0	1
7	26997480	Melanoma	all	Anti-PD-1 (pembrolizumab and nivolumab)	21	17	9.5	0	9.5	0.492
8	26997480	Melanoma	MAPKi	Anti-PD-1 (pembrolizumab and nivolumab)	8	6	25	0	25	0.473
9	26997480	Melanoma	non-MAPKi	Anti-PD-1 (pembrolizumab and nivolumab)	13	11	0	0	0	1
10	28552987	Urothelial cancer	all	Anti-PD-L1 (atezolizumab)	9	16	11.1	6.2	4.9	1
11	28552987	Urothelial cancer	smoking	Anti-PD-L1 (atezolizumab)	5	9	0	11.1	-11.1	1
12	28552987	Urothelial cancer	non-smoking	Anti-PD-L1 (atezolizumab)	4	7	25	0	25	0.364
13	29033130	Melanoma	all	Anti-PD-1 (nivolumab)	38	27	0	0	0	1
14	29033130	Melanoma	NIV3-PROG	Anti-PD-1 (nivolumab)	22	13	0	0	0	1
15	29033130	Melanoma	NIV3-NAIVE	Anti-PD-1 (nivolumab)	16	14	0	0	0	1
16	29301960	Clear cell renal cell carcinoma (ccRCC)	all	Anti-PD-1 (nivolumab)	11	13	0	0	0	1
17	29301960	Clear cell renal cell carcinoma (ccRCC)	VEGFRi	Anti-PD-1 (nivolumab)	6	1	0	0	0	1
18	29301960	Clear cell renal cell carcinoma (ccRCC)	non-VEGFRi	Anti-PD-1 (nivolumab)	5	12	0	0	0	1

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of NUP93. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.

> Lymphocyte [ TOP ]

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of NUP93. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by NUP93. > Immunoinhibitor > Immunostimulator > MHC molecule

> Immunoinhibitor [ TOP ]

> Immunostimulator [ TOP ]

> MHC molecule [ TOP ]

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of NUP93. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor

> Chemokine [ TOP ]

> Receptor [ TOP ]

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Distribution of NUP93 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype

> Immune subtype [ TOP ]

> Molecular subtype [ TOP ]

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Associations between NUP93 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade

> Overall survival [ TOP ]

> Stage [ TOP ]

> Grade [ TOP ]

Summary
Symbol	NUP93
Name	nucleoporin 93kDa
Aliases	KIAA0095; NIC96; 93 kDa nucleoporin; nucleoporin Nup93; Nuclear pore complex protein Nup93
Chromosomal Location	16q13
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content	Drugs targeting NUP93 collected from DrugBank database.

> Drugs from DrugBank database [ TOP ]
There is no record.

Browse NUP93